-
-
Dear all,
If anyone can recommend a randomisation platform that can be used for a double blinded trial with minimisation, I’d love to hear from you! Thanks all.
-
Hi there – great question!
Would you mind providing a little more information about your platform requirements and hopefully we will be able to find some possible options for you from the forum participants.
Thanks so much
-
Sure Jaime, thanks for the prompt. We are looking for a platform that we can use for randomisation of trial participants, IP allocation and re-supply when study IP dispensing visits occur. If it can track IP expiry and low stock levels even better! Since it is a double blind trial, we need to have restricted access so that blinded personnel only see blinded information.
-
Thanks so much for the extra information Laura.
There are a variety of commercial vendors who could offer this and perhaps it is best to take that discussion offline. I will send through an email soon.
Jaime
- You must be logged in to reply to this topic.
Disclaimer
The comments and resources posted here have been provided by
members of Beyond COVID-19: A solution-focussed forum
(‘Forum’) and other sources. They are offered for your reference
only and are not intended to represent the best or only approach to
any particular issue.
The Beyond COVID-19: A solution-focussed forum has not
attempted to evaluate any posted material.
Neither ACTA, as host of the Forum, nor the individuals or
collaborators on this Forum, make any guarantee with regard to the
accuracy, completeness or suitability of any advice or resource, and
they assume no responsibility or liability in connection with the
use or misuse of any material.
The comments and resources posted here should not be construed as
clinical or legal advice, and users should seek appropriate advice
to address specific facts and
circumstances.
Copyright in posted materials belongs to the respective owners,
whether or not a copyright notice appears on the screen displaying the materials.
.
